AZN · LONDON STOCK EXCHANGE ·
AstraZeneca PLC
Klygefa (gefurulimab) approved in the EU
Our AI’s take
The European Commission has approved Klygefa for adults with AChR antibody-positive generalised myasthenia gravis as an add-on to standard therapy.
The full digestion is for members. What is good, what is bad and why, the numbers that matter, and the chart, then ask about it by voice or text.
Join freeNew to announcements? Learn what an RNS is and why prices move.